Abstract
Terpenoid compounds of natural origin with antiviral activities, namely triterpenes and steroids, include compounds with potential future medical use as well as substances in different stages of clinical research and testing. These natural compounds have often been synthetically modified, the modification including both changes in the basic structure or mere substituent modifications.
Keywords: Sterols, Triterpenoids, Antiviral Activity, natural compounds
Anti-Infective Agents in Medicinal Chemistry
Title: Sterols and Triterpenoids with Antiviral Activity
Volume: 8 Issue: 3
Author(s): T. Rezanka, L. Siristova and K. Sigler
Affiliation:
Keywords: Sterols, Triterpenoids, Antiviral Activity, natural compounds
Abstract: Terpenoid compounds of natural origin with antiviral activities, namely triterpenes and steroids, include compounds with potential future medical use as well as substances in different stages of clinical research and testing. These natural compounds have often been synthetically modified, the modification including both changes in the basic structure or mere substituent modifications.
Export Options
About this article
Cite this article as:
Rezanka T., Siristova L. and Sigler K., Sterols and Triterpenoids with Antiviral Activity, Anti-Infective Agents in Medicinal Chemistry 2009; 8 (3) . https://dx.doi.org/10.2174/187152109788680207
DOI https://dx.doi.org/10.2174/187152109788680207 |
Print ISSN 1871-5214 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6018 |
Related Articles
-
DLEU2: A Meaningful Long Noncoding RNA in Oncogenesis
Current Pharmaceutical Design Regulation of Mitochondrial Function and its Impact in Metabolic Stress
Current Medicinal Chemistry Molecular Mechanism and Targets of the Antimicrobial Activity of Metal Nanoparticles
Current Topics in Medicinal Chemistry Aldo-Keto Reductase Family 1 Member B1 Inhibitors: Old Drugs with New Perspectives
Recent Patents on Anti-Cancer Drug Discovery Cross-Talk between Tumor Cells and the Microenvironment at the Metastatic Niche
Current Pharmaceutical Biotechnology Inhibition of RET Activated Pathways: Novel Strategies for Therapeutic Intervention in Human Cancers
Current Pharmaceutical Design Hypoxia-Inducible Factor-1 as Regulator of Angiogenesis in Rheumatoid Arthritis - Therapeutic Implications
Current Medicinal Chemistry Multi-Kinase Inhibitors
Current Medicinal Chemistry Managing Multi-Center Recruitment in the PLCO Cancer Screening Trial
Reviews on Recent Clinical Trials Overcoming Resistance to EGFR Inhibitors in NSCLC
Reviews on Recent Clinical Trials MicroRNA in the Pathogenesis and Prognosis of Esophageal Cancer
Current Pharmaceutical Design Chronic Myeloid Leukemia: Existing Therapeutic Options and Strategies to Overcome Drug Resistance
Mini-Reviews in Medicinal Chemistry Targeting CSCs in Tumor Microenvironment: The Potential Role of ROS-Associated miRNAs in Tumor Aggressiveness
Current Stem Cell Research & Therapy Effects of Natural Products on Mcl-1 Expression and Function
Current Medicinal Chemistry Review of the Biological Activity of Maslinic Acid
Current Drug Targets Fibroblast Growth Factor Receptor Inhibitors
Current Pharmaceutical Design New Developments in Targeted Analysis of Protein Posttranslational Modifications
Current Proteomics Volatile Disease Biomarkers in Breath: A Critique
Current Pharmaceutical Biotechnology Recent Developments in the Third Generation Inhibitors of Bcr-Abl for Overriding T315I Mutation
Current Medicinal Chemistry Secretory Clusterin: A Promising Target for Chemoresistance of Hepatocellular Carcinoma
Mini-Reviews in Medicinal Chemistry